Dr. Fiorentino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-723-7796
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 1999 - 2002
- University of ColoradoInternship, Internal Medicine, 1998 - 1999
- Stanford University School of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 1999 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus Start of enrollment: 2006 Aug 01
- A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease Start of enrollment: 2006 Aug 01
- A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 58 citationsLeukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary HypertensionJin Qian, Wen Tian, Xinguo Jiang, Rasa Tamosiuniene, Yon K. Sung
Hypertension. 2015-12-01 - 40 citationsXist ribonucleoproteins promote female sex-biased autoimmunity.Diana R Dou, Yanding Zhao, Julia A Belk, Yang Zhao, Kerriann M Casey
Cell. 2024-02-01 - 256 citationsDiagnostic criteria of ulcerative Pyoderma Gangrenosum a delphi consensus of international expertsEmanual Michael Maverakis, Chelsea Ma, Kanade Shinkai, David Fiorentino, Jeffrey P. Callen
JAMA Dermatology. 2018-04-01
Journal Articles
- Clinical Significance of Autoantibodies in Dermatomyositis and Systemic SclerosisDavid F Fiorentino, Lorinda Chung, ScienceDirect
Press Mentions
- Autoantibodies Signal Reduced Cancer Risk in DermatomyositisFebruary 17th, 2023
- FDA Approves New Drug, Sotyktu, for Treatment of Plaque PsoriasisSeptember 10th, 2022
- Reviewers' List December 2020August 12th, 2020
- Join now to see all
Professional Memberships
- Member
- Fellow
- Clinical Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: